NCT02658747View on ClinicalTrials.gov

Neutropenic Sepsis in Patients With Non-Small Cell Lung Cancer Treated With Single-Agent Docetaxel and Associated Resource Use in the UK

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

May 25, 2016

Primary Completion Date

July 25, 2016

Study Completion Date

July 25, 2016

Conditions
Non-Small Cell Lung Cancer
Interventions
OTHER

No intervention

No intervention administered in this study

Trial Locations (7)

BS2 8ED

Bristol Haematology and Oncology Centre, Bristol

CF14 2TL

Velindre Cancer Centre, Cardiff

SW10 9NH

Chelsea & Westminster Hospital, London

ME16 0FS

Maidstone Hospital; Kent Oncology Centre, Maidstone

OX3 7LE

Oxford University Hospitals NHS Trust - Churchill Hospital, Oxford

TR1 3LQ

Royal Cornwall Hospital, Truro

WF1 4DG

Pinderfields General Hospital; Dept of Haematology, Wakefield

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02658747 - Neutropenic Sepsis in Patients With Non-Small Cell Lung Cancer Treated With Single-Agent Docetaxel and Associated Resource Use in the UK | Biotech Hunter | Biotech Hunter